War on Disease
War on Disease
Invite
Back to Treatments
Treatment
Baricitinib
1
Conditions
30
Trials
10K
Participants
55%
Average Safety
Condition Evidence
COVID-19
30 trials Β· 10K participants
75% effectiveness Β· 55% safety
Baricitinib | DFDA